NAPOLITANO, Mariasanta
 Distribuzione geografica
Continente #
NA - Nord America 13.732
EU - Europa 5.162
AS - Asia 4.731
SA - Sud America 898
AF - Africa 125
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 16
Totale 24.688
Nazione #
US - Stati Uniti d'America 13.520
SG - Singapore 1.779
RU - Federazione Russa 1.329
CN - Cina 1.187
IT - Italia 1.043
DE - Germania 729
BR - Brasile 722
HK - Hong Kong 458
VN - Vietnam 412
FI - Finlandia 362
PL - Polonia 331
FR - Francia 281
GB - Regno Unito 271
IE - Irlanda 192
JP - Giappone 150
SE - Svezia 134
CA - Canada 124
IN - India 121
BD - Bangladesh 119
UA - Ucraina 118
KR - Corea 110
NL - Olanda 103
TR - Turchia 78
RO - Romania 64
AR - Argentina 58
IQ - Iraq 46
MX - Messico 45
AT - Austria 39
ID - Indonesia 35
PK - Pakistan 33
EC - Ecuador 32
ES - Italia 32
ZA - Sudafrica 31
UZ - Uzbekistan 24
CH - Svizzera 23
CO - Colombia 23
MA - Marocco 23
SA - Arabia Saudita 23
AU - Australia 21
BE - Belgio 21
VE - Venezuela 20
IR - Iran 19
CL - Cile 16
CZ - Repubblica Ceca 16
MY - Malesia 16
NP - Nepal 15
EG - Egitto 14
AE - Emirati Arabi Uniti 13
GR - Grecia 13
KE - Kenya 13
IL - Israele 12
CR - Costa Rica 11
UY - Uruguay 11
CI - Costa d'Avorio 10
DZ - Algeria 10
LT - Lituania 10
PH - Filippine 10
LB - Libano 9
TN - Tunisia 9
AL - Albania 8
OM - Oman 8
PY - Paraguay 8
TH - Thailandia 8
EU - Europa 7
JO - Giordania 7
BG - Bulgaria 6
DK - Danimarca 6
DO - Repubblica Dominicana 6
HR - Croazia 6
JM - Giamaica 6
KZ - Kazakistan 6
XK - ???statistics.table.value.countryCode.XK??? 6
RS - Serbia 5
TW - Taiwan 5
AZ - Azerbaigian 4
BH - Bahrain 4
BY - Bielorussia 4
PE - Perù 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BO - Bolivia 3
GT - Guatemala 3
KG - Kirghizistan 3
MD - Moldavia 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
PR - Porto Rico 3
QA - Qatar 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
EE - Estonia 2
HN - Honduras 2
LY - Libia 2
NO - Norvegia 2
PA - Panama 2
PS - Palestinian Territory 2
SC - Seychelles 2
Totale 24.662
Città #
Fairfield 1.598
Ashburn 1.443
Secaucus 1.362
Singapore 1.191
Houston 755
Woodbridge 704
San Jose 692
Seattle 633
Wilmington 618
Chandler 602
Cambridge 534
Hong Kong 440
Council Bluffs 343
Zgierz 302
Ann Arbor 292
Beijing 240
Santa Clara 222
Medford 193
Dublin 191
Los Angeles 190
Moscow 190
Des Moines 181
Helsinki 168
Dallas 160
Altamura 152
Tokyo 143
Lauterbourg 139
Ho Chi Minh City 130
Palermo 130
Princeton 128
Nanjing 110
Lawrence 106
Hefei 105
Hanoi 99
New York 92
San Diego 86
Boardman 85
Dearborn 80
Frankfurt am Main 78
São Paulo 68
Buffalo 55
Rome 55
London 54
The Dalles 53
Chicago 48
Nuremberg 48
Ludwigshafen am Rhein 43
Columbus 42
Milan 41
Phoenix 38
Shenyang 37
Jacksonville 35
Lappeenranta 35
Toronto 34
Izmir 32
Nanchang 32
Tianjin 32
Orem 31
Zhengzhou 31
Hebei 30
Denver 29
Brooklyn 28
Montreal 27
Atlanta 26
Seoul 26
Shanghai 25
Falls Church 24
Jiaxing 24
Mumbai 24
Redwood City 24
Stockholm 24
Guangzhou 23
Tulsa 23
Chennai 22
Ningbo 22
Brussels 21
Haiphong 20
Warsaw 20
Amsterdam 19
Belo Horizonte 19
Changsha 19
Istanbul 19
Rio de Janeiro 19
Brasília 18
Jinan 17
Ottawa 17
Tashkent 17
Baghdad 16
Hangzhou 16
Kilburn 16
Paris 16
Seongnam 16
Saint Petersburg 15
Bengaluru 14
Johannesburg 14
Orange 14
Salt Lake City 14
San Paolo di Civitate 14
Vancouver 14
City of London 13
Totale 16.569
Nome #
[Haemocoagulative modifications correlated with pregnancy] 935
Real-World Prophylaxis Outcomes with rIX-FP and rFIXFc for Males with Hemophilia B: Pooled Analysis of Medical Chart Data from Germany and Italy 748
Absolute Lymphocyte Count Is Unrelated to Overall Survival in Newly Diagnosed Elderly Patients with Multiple Myeloma Treated with Immunomodulatory Drugs. 486
Management of Pregnancy, Delivery, and Postpartum in Italian Carriers and Women With Haemophilia A and B 408
Iron-dependent erythropoiesis in women with excessive menstrual blood losses and women with normal menses 355
Clinical phenotype and response to different lines of therapy in elderly with immune thrombocytopenia: A retrospective study 327
Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies 272
Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system 270
Peripheral circulating cells with paroxysmal nocturnal haemoglobinuria phenotype after a first episode of cerebral sinus vein thrombosis: Results from a multicentre cross-sectional study 263
Acquired haemophilia in cancer: A systematic and critical literature review 256
Optimal Duration of Low Molecular Weight Heparin for the Treatment of Cancer-Related Deep Vein Thrombosis: The Cancer-DACUS Study. 255
Buffy coat-derived platelets cryopreserved using a new method: Results from a pivotal clinical trial on thrombocytopenic patients with acute leukaemia 251
Replacement therapy for bleeding episodes in factor VII deficiency: A prospective evaluation 247
Role of clinical and laboratory parameters for treatment choice in patients with inherited FVII deficiency undergoing surgical procedures: evidence from the STER registry 241
Hematopoietic peripheral circulating blood stem cells as an independent marker of good transfusion management in patients with β-thalassemia: results from a preliminary study 240
Abdominal aortic thrombosis secondary to reactive thrombocytosis in a patient with iron deficiency anemia 240
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: a communication from the Platelet Physiology SSC 239
A Multicenter Real-Life Study On Anticoagulant Treatment With Direct Oral Anticoagulants In Patients With Ph Negative Myeloproliferative Neoplasms 236
Acquired Hemophilia A Associated with Venous Thrombosis and Very High Inhibitor Titer: A Challenging Scenario 233
Activated prothrombin complex concentrate (FEIBA®) in acquired haemophilia A: a large multicentre Italian study - the FAIR Registry 231
null 231
Hereditary combined deficiency of the vitamin K-dependent clotting factors 230
Combined Point of Care Tools Are Able to Improve Treatment Adherence and Health-Related Quality of Life in Patients with Severe Hemophilia: An Observational Prospective Study 226
Autoantibody Inhibitor Eradication In Acquired Hemophilia Associated with Cancer: a Retrospective Analysis 225
Incidence of venous thromboembolism and use of anticoagulation in hematological malignancies: Critical review of the literature 224
Antimicrobial prophylaxis in patients with immune thrombocytopenia treated with rituximab: a retrospective multicenter analysis 224
Buffy coat-derived platelets cryopreserved using a new method: Results from in vitro studies 218
Tailoring haemophilia A prophylaxis with BAY 81-8973: A case series 216
Antimicorbial prophylaxis in patients with immune thrombocytopenia treated with rituximab:a retrospective analysis 213
Factor VII Deficiency: Clinical Phenotype, Genotype and Therapy 212
Immunosenescence and lymphomagenesis 212
Benign intracranial hypertension associated to blood coagulation derangements 211
Clinical course of isolated distal deep vein thrombosis in patients with active cancer: A multicenter cohort study 210
Late onset of unilateral optic disk edema secondary to treatment with imatinib mesylate 210
Atypical presentations of thrombotic thrombocytopenic purpura in middle-aged women with recurrent cerebral macrovascular thrombosis: a case report 209
Patient preferences in the treatment of hemophilia A: impact of storage conditions on product choice 202
Quality of Life in Patients With Cancer Under Prolonged Anticoagulation for High-Risk Deep Vein Thrombosis: a Long-Term Follow-Up 202
COMPARISON OF CLINICAL AND LABORATORY DATA, INCLUDING JAK-2 46/1 HAPLOTYPE, BETWEEN PATIENTS WITH IDIOPATHIC ERYTHROCYTOSIS AND POLYCYTHEMIA VERA. 196
Cardio-oncology in multiple myeloma: is it time for a specific focus? 192
Correlation between FIX genotype and pharmacokinetics of Nonacog alpha according to a multicentre Italian study 191
Management of kidney transplantation in a factor VII-deficient patient: case report. 189
Bone marrow characteristics predict outcome in a multicenter cohort of primary immune thrombocytopenia patients treated with thrombopoietin analogues 189
Clinical history of thrombosis before diagnosis of overt myeloproliferative neoplasms in triple negative patients 181
JAK2 ALLELE BURDEN IN PATIENTS WITH PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASMS 180
Emotions and Opinions of Adult Patients with Haemophilia During the COVID-19 (Coronavirus Disease 2019) Pandemic Caused by SARS-CoV-2: A Monocentric Survey 178
Pharmacokinetic properties of recombinant FVIIa in inherited FVII deficiency account for a large volume of distribution at steady state and a prolonged pharmacodynamic effect 177
Cancers in Patients with von Willebrand Disease: A Survey from the Italian Association of Haemophilia Centres 176
Clostridium difficile Induced Inflammasome Activation and Coagulation Derangements 174
Adverse Events in Treatment of Inherited Factor VII Deficiency: Final Analysis of the STER 170
Coexistence of Von Willebrand disease and gastrointestinal stromal tumor (G.I.S.T): Case report of a rare and challenge association 170
The Essential Thrombocythemia in 2020: What We Know and Where We Still Have to Dig Deep 170
Genetics and Pathogenetic Role of Inflammasomes in Philadelphia Negative Chronic Myeloproliferative Neoplasms: A Narrative Review 169
Status of Recombinant Factor VIII Concentrate Treatment for Hemophilia a in Italy: Characteristics and Clinical Benefits 167
Effective Hemostasis During Minor Surgery in a Case of Hereditary Combined Deficiency of Vitamin K-dependent Clotting Factors 166
Le emergenze emorragiche in ematologia 165
"Long term anticoagulant treatment management in patients with portal vein thrombosis at high bleeding risk" 165
OC-01 - Clinical history of cancer patients with isolated distal deep vein thrombosis: a multicenter cohort study 165
Low dose of aPCC after the initial treatment in acquired haemophilia A is useful to reduce bleeding relapses: Data from the FAIR registry 165
Addressing the impact of SARS-CoV-2 infection in persons with congenital bleeding disorders: The Italian MECCOVID-19 study 164
Lymphomas and thyroid: Bridging the gap 163
Hematopoietic Peripheral Circulating Blood Stem Cells As an Independent Marker of Good Transfusion Management in Patients with Beta-Thalassemia 163
Natural and engineered carboxy-terminal variants: decreased secretion and gain-of-function result in asymptomatic coagulation factor VII deficiency. 162
Cryopreserved platelets: from in vitro thrombin generation potential to in vivo safety 162
Combined use of antifibrinolytics and activated prothrombin complex concentrate (aPCC) is not related to thromboembolic events in patients with acquired haemophilia A: data from FAIR Registry 162
Can we compare haemophilia carriers with clotting factor deficiency to male patients with mild haemophilia? 162
Invasive procedures and minor surgery in factor VII deficiency 159
Bleeding Management of Uterine Conization Using a Pasteurized FVIII/VWF Concentrate in a Woman Affected by Type 2A von Willebrand Disease 156
Evidence of jak2 val617phe positive essential thrombocythemia with splanchnic thrombosis during estroprogestinic treatment 156
Future directions in acquired hemophilia A 156
Replacement therapy in inherited factor VII deficiency: Occurrence of adverse events and relation with surgery 156
Vitamin K-induced modification of coagulation phenotype in VKORC1 homozygous deficiency 155
Personalized prophylaxis with simoctocog-alfa(human-cl rhFVIII):A real-life experience on children and moderate haemophilia A patients 155
Inhibitors to factor VII in congenital factor VII deficiency 154
Coronary artery stenosis treatment in aging patients with inherited Factor VII deficiency: Where do we stand? 154
Ultrasonography-guided central venous catheterisation in haematological patients with severe thrombocytopenia 153
The Prevalence of Chronic Cerebrospinal Venous Insufficiency in Meniere Disease: 24-Month Follow-up after Angioplasty 153
Bleeding symptoms at disease presentation and prediction of ensuing bleeding in inherited FVII deficiency 153
Prophylaxis In Congenital Factor VII Deficiency, Indications, Efficacy and Safety: Results of the STER 152
Anomalie della coagulazione e angiodisplasie 152
Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management 152
Management of Venous ThromboEmbolism in patients with acute leukemia at high bleeding risk: a multicenter study 149
Glucosylsphingosine (Lyso-Gb1) as a reliable biomarker in Gaucher disease: a narrative review 147
Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review 147
Replacement Therapy for Minor Surgery and Invasive Procedures in Factor VII Deficiency: The STER Experience 146
Clinical and biological data on the use of hydroxychloroquine against SARS-CoV-2 could support the role of the NLRP3 inflammasome in the pathogenesis of respiratory disease 142
Recombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation - the surgical STER 141
Sorafenib as a feasible therapeutic option in haemophiliacs with hepatocellular carcinoma 141
The Effect of Fluctuating Temperature on the Stability of Turoctocog Alfa for Hemophilia A 140
Vitamin K deficiency bleeding leading to a diagnosis of Crohn’s Disease 137
Proposal and validation of a novel quantitative approach (QUEM) for the evaluation of menstrual blood losses. Preliminary implementation for the management of menorrhagia in congenital bleeding disorders. 135
Diagnosis and management of Evans syndrome in adults: first consensus recommendations 131
Subcortical ischaemic changes in young hypertensive patients: frequency, effect on cognitive performance and relationship with markers of endothelial and haemostatic activation 131
Incidence and Management Of Venous Thrombosis In Acute Leukemia: A Multicenter Study 130
[Hypercoagulability during pregnancy: evidences for a thrombophilic state] 127
Kinesiotaping for the Treatment of Haematomas in Haemophiliacs: a Case Control Study 127
Oral high-dose sucrosomial iron vs intravenous iron in sideropenic anemia patients intolerant/refractory to iron sulfate: a multicentric randomized study 126
Paroxysmal nocturnal haemoglobinuria: When delay in diagnosis and long therapy occurs 124
Fostering drug.storage,preparation and treatment modalities improves adherence to treatment with turoctocog-alfa in patients with haemophilia A:results from a short term follow-up 124
Functional In Vitro Studies Of Buffy Coat Pooled Platelets Cryopreserved In Dimethyl-Sulphoxide With a New System 121
Plasma viscosity pattern and erythrocyte aggregation in two patients with congenital afibrinogenemia 121
Totale 20.244
Categoria #
all - tutte 86.207
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.207


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021222 0 0 0 0 0 0 0 0 0 0 0 222
2021/20221.627 120 268 72 73 46 80 86 110 179 209 136 248
2022/20232.091 226 409 61 191 215 303 144 192 212 19 76 43
2023/2024980 54 124 95 185 77 145 107 42 21 17 23 90
2024/20252.789 81 278 324 220 93 94 192 200 205 257 289 556
2025/202610.685 503 1.797 548 1.099 927 1.129 1.168 959 944 842 399 370
Totale 25.504